Enzo Biochem (NYSE:ENZ) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Enzo Biochem (NYSE:ENZ) in a research report released on Wednesday morning. The brokerage issued a hold rating on the medical research company’s stock.

Enzo Biochem Stock Down 15.4 %

Enzo Biochem stock opened at $0.32 on Wednesday. The company has a fifty day simple moving average of $0.43 and a 200-day simple moving average of $0.74. Enzo Biochem has a 12-month low of $0.25 and a 12-month high of $1.28.

Enzo Biochem (NYSE:ENZ) last announced its quarterly earnings results on Monday, March 17th. The medical research company reported ($0.02) earnings per share (EPS) for the quarter. The business had revenue of $7.33 million for the quarter. Enzo Biochem had a negative return on equity of 7.96% and a negative net margin of 75.34%.

Institutional Trading of Enzo Biochem

A number of large investors have recently bought and sold shares of ENZ. Mink Brook Asset Management LLC purchased a new stake in shares of Enzo Biochem in the fourth quarter valued at about $577,000. Lepercq Multi Asset Fund acquired a new stake in Enzo Biochem during the 4th quarter worth approximately $88,000. Wittenberg Investment Management Inc. grew its stake in shares of Enzo Biochem by 60.1% in the 4th quarter. Wittenberg Investment Management Inc. now owns 187,537 shares of the medical research company’s stock valued at $134,000 after purchasing an additional 70,400 shares during the last quarter. Virtu Financial LLC acquired a new position in shares of Enzo Biochem in the fourth quarter valued at approximately $35,000. Finally, Geode Capital Management LLC raised its stake in shares of Enzo Biochem by 3.3% during the third quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock worth $413,000 after purchasing an additional 11,742 shares during the last quarter. Institutional investors and hedge funds own 36.90% of the company’s stock.

About Enzo Biochem

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.